...
首页> 外文期刊>Journal of Pharmaceutical and Biomedical Analysis: An International Journal on All Drug-Related Topics in Pharmaceutical, Biomedical and Clinical Analysis >Characterization of a technique for rapid pharmacokinetic studies of multiple co-eluting compounds by LC/MS/MS.
【24h】

Characterization of a technique for rapid pharmacokinetic studies of multiple co-eluting compounds by LC/MS/MS.

机译:通过LC / MS / MS对多种共洗脱化合物进行快速药代动力学研究的技术表征。

获取原文
获取原文并翻译 | 示例
           

摘要

A method for rapid pharmacokinetic screening of multiple potential drug candidates has been developed. This technique, based on the ability of liquid chromatography coupled with tandem mass spectrometry (LC/MS/MS) to independently monitor multiple components, enables the quantification of substances which may or may not be chromatographically resolved. Our results indicate that the limit of quantitation and accuracy of this multiple-compound LC/MS/MRM quantitation method are comparable to a single-compound LC/MS/MRM quantitation method. No apparent ion suppression due to the existence of extraneous compounds in the analytical solution and biological matrix effect are observed in the range of the calibration curve. The issue of potential residual molecule cross-talk interference existing in the multiple-reaction monitoring mode has been discussed. This multiple-compound LC/MS/MRM quantitation method can be used for high throughput pharmacokinetic screening and to assay mixtures that have co-eluting analytes or similar m/z of precursor/product ion pairs.
机译:已经开发了一种用于快速筛选多种潜在药物候选物的方法。这项技术基于液相色谱与串联质谱联用(LC / MS / MS)的能力,可独立监控多种组分,从而能够定量分析可能色谱或未色谱分离的物质。我们的结果表明,这种多化合物LC / MS / MRM定量方法的定量极限和准确性与单化合物LC / MS / MRM定量方法相当。在校准曲线范围内,未观察到由于分析溶液中存在外来化合物而导致的明显离子抑制,以及未观察到生物基质效应。讨论了在多反应监测模式下存在的潜在残留分子串扰干扰问题。这种多化合物LC / MS / MRM定量方法可用于高通量药代动力学筛选,并用于分析具有共洗脱分析物或前体/产物离子对的相似m / z的混合物。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号